Cancer stem cells: are we missing the target?

J Natl Cancer Inst. 2004 Apr 21;96(8):583-5. doi: 10.1093/jnci/djh095.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Benzamides
  • Drug Design
  • Drug Resistance, Neoplasm
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Neoplasms / drug therapy*
  • Neoplastic Stem Cells / drug effects*
  • Piperazines / pharmacology
  • Pyrimidines / pharmacology
  • Survival

Substances

  • Antineoplastic Agents
  • Benzamides
  • Enzyme Inhibitors
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate